MaxCyte Documente
Documente
0
Ticker
MXCT
ISIN
US57777K1060
MaxCyte SEC Filings
Tip | Raport | Dată |
|---|---|---|
| Nu sunt disponibile documente | ||
MaxCyte Documente 2026
Această pagină conține toate documentele oficiale și depunerile SEC pentru acțiunea MaxCyte (MXCT, ISIN: US57777K1060). Aceasta include rapoarte anuale (Form 10-K), rapoarte trimestriale (Form 10-Q) și tranzacții interne (Form 4). În prezent sunt disponibile 0 documente. Datele sunt actualizate regulat pentru a oferi investitorilor o prezentare generală completă a depunerilor de reglementare ale MaxCyte.
MaxCyte Analiza acțiunilor
MaxCyte MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products.